Swiss National Bank Adaptive Biotechnologies Corp Transaction History

Swiss National Bank

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$3.46 - $5.33 $77,850 - $119,925	-22,500 Reduced 10.13%	199,600 $978,000
Q3 2023 Nov 08, 2023	BUY	$5.07 - $8.44 $19,266 - $32,071	3,800 Added 1.74%	222,100 $1.21 Million
Q2 2023 Aug 09, 2023	BUY	$6.19 - $8.78 $14,237 - $20,194	2,300 Added 1.06%	218,300 $1.46 Million
Q1 2023 May 10, 2023	SELL	$7.8 - $10.11 $198,900 - $257,805	-25,500 Reduced 10.56%	216,000 $1.91 Million
Q4 2022 Feb 08, 2023	BUY	$6.26 - $9.34 $33,804 - $50,436	5,400 Added 2.29%	241,500 $1.85 Million
Q3 2022 Nov 09, 2022	BUY	$6.5 - $12.67 $16,900 - $32,942	2,600 Added 1.11%	236,100 $1.68 Million
Q2 2022 Aug 09, 2022	BUY	$6.4 - $14.73 $106,240 - $244,518	16,600 Added 7.65%	233,500 $1.89 Million
Q1 2022 May 09, 2022	BUY	$10.12 - $28.9 $154,836 - $442,170	15,300 Added 7.59%	216,900 $3.01 Million
Q3 2021 Nov 08, 2021	BUY	$30.02 - $39.87 $63,042 - $83,727	2,100 Added 1.05%	201,600 $6.85 Million
Q2 2021 Aug 06, 2021	SELL	$32.22 - $44.59 $115,992 - $160,524	-3,600 Reduced 1.77%	199,500 $8.15 Million
Q1 2021 May 07, 2021	BUY	$37.26 - $67.74 $130,410 - $237,089	3,500 Added 1.75%	203,100 $8.18 Million
Q4 2020 Feb 05, 2021	BUY	$45.01 - $65.47 $1.22 Million - $1.77 Million	27,000 Added 15.64%	199,600 $11.8 Million
Q3 2020 Nov 09, 2020	BUY	$35.79 - $48.81 $121,686 - $165,954	3,400 Added 2.01%	172,600 $8.39 Million
Q2 2020 Aug 05, 2020	BUY	$24.95 - $48.38 $4.22 Million - $8.19 Million	169,200 New	169,200 $8.19 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.